We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03576365
Recruitment Status : Recruiting
First Posted : July 3, 2018
Last Update Posted : February 14, 2023
Sponsor:
Collaborator:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Information provided by (Responsible Party):
University of Minnesota

Brief Summary:
The purpose of this study is to pilot test a version of the intervention that has been tailored for participants with dysphonia. The study seeks to determine if the adapted intervention: a) increases perceived control over voice-related stressors and b) decreases stress and distress resulting from voice problems. The study will also explore the usability and acceptability of the program. The goal is to help people with voice problems achieve better voice and quality of life outcomes.

Condition or disease Intervention/treatment Phase
Functional Dysphonia Voice Disorders Dysphonia Behavioral: VOICE Intervention Arm Behavioral: Information-Only Arm Not Applicable

Detailed Description:

In the investigator's voice clinic, a high prevalence of severe distress has been identified. Distress and voice handicap were positively correlated, and perceived control moderated the relationship. Perceived control is associated with less distress in a variety of medical conditions, has an impact beyond that of coping and personality, and can be increased via targeted intervention.

This is a randomized controlled trial. Participants will be randomly assigned to one of the two groups. Both groups involve completing surveys and receiving information online about voice problem.

Participants complete an initial baseline assessment focused on voice function and emotions, including items from the Perceived Control Scale, Voice Handicap Index-10, Perceived Stress Scale, Brief Symptom Inventory-18. Finally, the participants will complete some brief feedback questions about the material.

Next, twice a week for up to three weeks participants will complete check-ins from the online program. Participants in the intervention arm will complete self-guided exercises and brief assessment questions. Participants in the information-only arm will complete mini knowledge quizzes.

All participants will complete brief a post-intervention assessment parallel to the baseline assessment. Lastly, they will have an opportunity to provide final feedback on their experience.

Follow-up with each participant will occur one and three months after finishing the program. Questionnaires will be sent via email including Voice Handicap Index-10, Present Perceived Control-8, and questions regarding treatment adherence and voice outcomes.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 70 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Masking Description: Participants are not aware of which treatment arm they are assigned.
Primary Purpose: Treatment
Official Title: Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention
Actual Study Start Date : April 11, 2016
Estimated Primary Completion Date : June 2023
Estimated Study Completion Date : June 2024

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Voice Disorders

Arm Intervention/treatment
Experimental: VOICE Intervention Arm
Participants participate in the online VOICE program to learn about perceived control and stress reduction to improve voice outcomes.
Behavioral: VOICE Intervention Arm

Introductory and background information about voice problems and psychosocial distress

  • Examples of concerns raised by patients with voice problems (e.g., "I feel left out of conversations because of my voice problem")
  • Information about perceived control and how improving perceived control can lead to decreased distress
  • Examples of strategies that have helped patients identify controllable and uncontrollable aspects of their voice problems (e.g., "I learned to plan to take breaks to rest my voice between teaching classes")
  • Self-guided exercises designed to help improve perceived control and develop better management skills for voice problem symptoms

Sham Comparator: Information-Only Arm
Participants participate in the information only program to learn about voice problems, anatomy and physiology.
Behavioral: Information-Only Arm

General introduction of the program and background on voice related information in an interactive manner

  • Examples of what patients want to learn more about the voice (e.g., "I would like to learn more about how the voice works when it is healthy")
  • Information on the anatomy of the voice and how the voice works
  • Educational materials to help understand voice physiology and function
  • Self-guided learning exercises (e.g., "what are some things about vocal function that you would like to learn more about?")




Primary Outcome Measures :
  1. Perceived Control [ Time Frame: 2 weeks ]

    Change from baseline assessment using a questionnaire, Perceived Present Control-8 (PPC-8).

    The PPC-8 questionnaire has 8 questions about perceptions of present control over their voice problem, assessed on a 4-point Likert-type scale, with scores of 1-4 (1=Strongly Disagree, 2=Disagree Somewhat, 3=Agree Somewhat, 4=Strongly Agree). Total scores range from 1-32. Higher scores indicate more perceived control over the patient's voice problems.



Secondary Outcome Measures :
  1. Voice Handicap [ Time Frame: 2 weeks ]

    Change from baseline assessment using a questionnaire, Voice Handicap Index-10 (VHI-10).

    The VHI-10 questionnaire has 10 questions about voice problems and the effect it has on the patients life, assessed on a 4-point Likert-type scale, with scores of 0-4 (0=Never, 1=Almost Never, 2=Sometimes, 3=Almost Always, 4=Always). Total scores range from 0-40. Higher scores indicate a more problematic voice. The clinical cutoff for a problematic voice is a VHI-10 score of 10, where scores >10 indicate voice problems. A change of at least 6 points is clinically significant.


  2. Perceived Stress [ Time Frame: 2 Weeks ]

    Change from baseline assessment using a questionnaire, Perceived Stress Scale-4 (PSS-4).

    The PSS-4 questionnaire has 4 questions about perceived stress, assessed on a 5-point Likert-type scale, with scores of 0-4 (0=Never, 1=Almost Never, 2=Sometimes, 3=Fairly Often, 4=Very Often). Total scores range from 0-16. Higher scores indicate more perceived stress in the patient's life.


  3. Psychological Symptoms [ Time Frame: 2 weeks ]

    Change from baseline assessment using a questionnaire, Brief Symptom Inventory-18 (BSI-18).

    The BSI-18 questionnaire has 18 questions about psychological symptoms, assessed on a 5-point Likert-type scale, with scores of 0-4 (0=Not at all, 1=A little bit, 2=Moderately, 3=Quite a bit, 4=Extremely). Total scores range from 0-72. Higher scores indicate more extreme psychological symptoms. Patients with "High Risk" psychological symptoms have a score of 57 (75 percentile) or greater.



Other Outcome Measures:
  1. Intervention Module Acceptability [ Time Frame: Baseline and at 2 weeks ]
    Examine the acceptability and usability of the adapted intervention based on feedback from participants via a questionnaire.

  2. Patients' Adherence to Voice Therapy and Treatment [ Time Frame: 2 weeks to 2 years ]
    Examine treatment adherence indicators available in the participants' medical charts after intervention is completed (e.g.., did they attend recommended speech therapy sessions, how adherent were they to their speech therapy exercise regimens, how many visits did it take for them to reach treatment goals). This will be assessed through a medical chart review and reported as a percent of sessions attended, percent exercises completed, and number of visits. All measures will be given equal weight and be used together to assess treatment adherence.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Patients who are seen at the Otolaryngology Clinic (University of Minnesota Health Clinics and Surgery Center, or Fairview Hospital Maple Grove or Southdale) with Muscle Tension Dysphonia
  2. Patients between 18-80 years of age experiencing a voice problem
  3. Scored high (>10) on the Voice Handicap Index (VHI-10)
  4. Has the ability to complete informed consent process
  5. Interested in using an online program/intervention
  6. Has reliable access to internet

Exclusion Criteria:

  1. Patients who have clinical need for concurrent treatment will be excluded to decrease confounding introduced by having multiple simultaneous interventions. This may include:

    1. Concurrent laryngeal lesion requiring immediate operative or other intervention
    2. Concurrent participation in speech therapy
    3. Concurrent need for new medications that may directly affect voice-related symptoms
  2. Participant has a Speech Language Pathology visit scheduled in two weeks or less from when they will start the program (if applicable)
  3. Unable to read English (as determined by their ability to complete the clinic intake forms)
  4. Female and pregnant
  5. Prisoner
  6. Unable to provide informed consent (e.g., patients with dementia)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03576365


Contacts
Layout table for location contacts
Contact: Ali Stockness, MPH 6513533018 ext 33018 nicho656@umn.edu

Locations
Layout table for location information
United States, Minnesota
University of Minnesota Health Maple Grove Clinic Recruiting
Maple Grove, Minnesota, United States, 55369
Contact: Ali Stockness, MPH    651-626-3018 ext 63018    voice@umn.edu   
University of Minnesota Health Clinics and Surgeries Otolaryngology Clinic Recruiting
Minneapolis, Minnesota, United States, 55455
Contact: Ali Stockness, MPH    651-626-3018 ext 63018    voice@umn.edu   
Sponsors and Collaborators
University of Minnesota
National Institute on Deafness and Other Communication Disorders (NIDCD)
Investigators
Layout table for investigator information
Principal Investigator: Stephanie Misono, MD, MPH University of Minnesota
Publications:
Layout table for additonal information
Responsible Party: University of Minnesota
ClinicalTrials.gov Identifier: NCT03576365    
Other Study ID Numbers: ENT-2017-25834
K23DC016335-01 ( U.S. NIH Grant/Contract )
First Posted: July 3, 2018    Key Record Dates
Last Update Posted: February 14, 2023
Last Verified: February 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University of Minnesota:
Perceived Control
Distress
Additional relevant MeSH terms:
Layout table for MeSH terms
Dysphonia
Hoarseness
Voice Disorders
Laryngeal Diseases
Respiratory Tract Diseases
Otorhinolaryngologic Diseases
Neurologic Manifestations
Nervous System Diseases
Respiration Disorders
Signs and Symptoms, Respiratory